PT‑141 10mg (Bremelanotide) is our melanocortin receptor - targeting peptide for laboratories examining central MC3R and MC4R pathways. Researchers use this format to profile receptor binding, intracellular signalling cascades, and pharmacodynamic behaviour across neuroendocrine models.

The 10mg presentation is well suited to dose-ranging, cross-species receptor work, or combination experiments with other alpha‑MSH analogues and fragments such as MT‑2 or KPV. Lyophilised powder allows precise reconstitution to the concentrations your protocols specify.

PT‑141 from Ascend Labs is supplied strictly as a research compound, with COA and batch data accessible to support publication-quality work.

Disclaimer: For scientific research use only. Not for human or animal use or consumption.